Paloma Partners Management Co Takes Position in Nu Skin Enterprises, Inc. (NUS)

Paloma Partners Management Co purchased a new position in Nu Skin Enterprises, Inc. (NYSE:NUS) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 4,214 shares of the company’s stock, valued at approximately $234,000.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Creative Planning boosted its position in Nu Skin Enterprises by 38.5% in the first quarter. Creative Planning now owns 1,800 shares of the company’s stock worth $100,000 after buying an additional 500 shares in the last quarter. TrimTabs Asset Management LLC boosted its position in Nu Skin Enterprises by 88.7% in the first quarter. TrimTabs Asset Management LLC now owns 2,349 shares of the company’s stock worth $130,000 after buying an additional 1,104 shares in the last quarter. Independent Portfolio Consultants Inc. boosted its position in Nu Skin Enterprises by 1.7% in the first quarter. Independent Portfolio Consultants Inc. now owns 2,375 shares of the company’s stock worth $132,000 after buying an additional 40 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in Nu Skin Enterprises by 23.0% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,506 shares of the company’s stock worth $139,000 after buying an additional 468 shares in the last quarter. Finally, LS Investment Advisors LLC boosted its position in Nu Skin Enterprises by 1,022.1% in the first quarter. LS Investment Advisors LLC now owns 3,658 shares of the company’s stock worth $203,000 after buying an additional 3,332 shares in the last quarter. 84.53% of the stock is owned by institutional investors and hedge funds.

Shares of Nu Skin Enterprises, Inc. (NYSE NUS) traded up 3.16% during trading on Friday, reaching $55.48. 995,807 shares of the company’s stock were exchanged. The stock has a market capitalization of $2.94 billion, a price-to-earnings ratio of 18.56 and a beta of 1.31. Nu Skin Enterprises, Inc. has a 52 week low of $46.35 and a 52 week high of $66.04. The stock has a 50 day moving average price of $61.67 and a 200-day moving average price of $56.55.

Nu Skin Enterprises (NYSE:NUS) last announced its quarterly earnings data on Wednesday, August 2nd. The company reported $0.77 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.69 by $0.08. The business had revenue of $550.10 million for the quarter, compared to analyst estimates of $548.09 million. Nu Skin Enterprises had a net margin of 7.53% and a return on equity of 24.14%. The company’s revenue was down 8.4% on a year-over-year basis. During the same period in the prior year, the firm posted $0.79 EPS. Analysts predict that Nu Skin Enterprises, Inc. will post $3.23 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 13th. Investors of record on Friday, August 25th will be issued a $0.36 dividend. The ex-dividend date is Wednesday, August 23rd. This represents a $1.44 annualized dividend and a yield of 2.60%. Nu Skin Enterprises’s payout ratio is 48.81%.

COPYRIGHT VIOLATION NOTICE: This piece of content was originally published by BNB Daily and is owned by of BNB Daily. If you are accessing this piece of content on another publication, it was illegally copied and republished in violation of US and international copyright laws. The original version of this piece of content can be read at https://www.baseball-news-blog.com/2017/08/19/paloma-partners-management-co-invests-234000-in-nu-skin-enterprises-inc-nus-updated-updated-updated.html.

A number of research firms have recently weighed in on NUS. TheStreet upgraded shares of Nu Skin Enterprises from a “c+” rating to a “b” rating in a research note on Wednesday, August 2nd. Stifel Nicolaus set a $50.00 price objective on shares of Nu Skin Enterprises and gave the stock a “sell” rating in a research note on Thursday, August 3rd. Pivotal Research reiterated a “buy” rating and issued a $65.00 price objective on shares of Nu Skin Enterprises in a research note on Thursday, May 4th. Zacks Investment Research lowered shares of Nu Skin Enterprises from a “hold” rating to a “sell” rating in a research note on Saturday, June 24th. Finally, ValuEngine raised shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a report on Friday, June 2nd. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and six have given a buy rating to the company. The company presently has an average rating of “Hold” and an average target price of $62.88.

In other Nu Skin Enterprises news, President Ryan S. Napierski sold 8,000 shares of the stock in a transaction that occurred on Tuesday, July 25th. The shares were sold at an average price of $65.00, for a total value of $520,000.00. Following the completion of the sale, the president now owns 68,170 shares of the company’s stock, valued at $4,431,050. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, General Counsel D Matthew Dorny sold 7,500 shares of the firm’s stock in a transaction that occurred on Thursday, August 10th. The stock was sold at an average price of $60.88, for a total transaction of $456,600.00. Following the sale, the general counsel now directly owns 52,230 shares of the company’s stock, valued at approximately $3,179,762.40. The disclosure for this sale can be found here. Insiders sold 31,750 shares of company stock worth $1,946,810 in the last 90 days. 5.20% of the stock is currently owned by insiders.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.

Institutional Ownership by Quarter for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply